The global mRNA vaccine market was valued at US$ 21.7 billion in 2023, reflecting the tail-end of heightened pandemic-era sales. However, with mass COVID-19 immunization campaigns tapering off and healthcare systems focusing on broader preventive strategies, the market is projected to contract at a compound annual growth rate (CAGR) of -4.3% over the forecast period. By 2034, the market size is...